| Filed On | Filing |
|---|---|
| 21 Jul 2022 |
8-K/A: Financial Statements and Exhibits
On March 25, 2022, Axsome Therapeutics, Inc. (the “Company" or "acquirer”) entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Jazz Pharmaceuticals plc, pursuant to which the Company will acquire Sunosi (the “Product... |
| 31 Mar 2022 | 8-K/A: Entry into a Material Definitive Agreement |
| 22 Sep 2020 | 8-K/A: Other Events |
Loading...
